JP Patent

JP5066095B2 — 染色体ｄｎａに標的化されるオリゴマーによる遺伝子発現の調節

Assigned to University of Texas System · Expires 2012-11-07 · 14y expired

What this patent protects

Patent listed against givosiran-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
JP5066095B2
Jurisdiction
JP
Classification
—
Expires
2012-11-07
Drug substance claim
No
Drug product claim
No
Assignee
University of Texas System
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.